Intrinsiqq
Baird Medical Investment Holdings Inc. logo

Baird Medical Investment Holdings Inc. Quality Score

BDMD

Compare
Quality8

Weak across most dimensions. This doesn't mean avoid, but the burden of proof is on the bull case.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
0/100
-0.1x

Negative earnings, no valuation support

Cash Flow Multiple
0/100
-1.4x

Negative FCF, no valuation support

Revenue Growth
0/100
-13.7%

Below 2%, essentially flat

Cash Flow Growth
0/100
Negative FCF

FCF negative, burning cash after capex

Business Quality & Capital Allocation

Share Dilution
80/100
0.0%

Roughly flat, no meaningful dilution

Margin Trend
0/100
-156.1pp

Contracted >2pp, margin pressure

Capital Structure
0/100
$19M

Positive debt with no FCF to service it

2022
$2.00M
$7.00M
2023
$2.00M
$12.0M
2024
$3.00M
$21.0M
2025
$178321
$19.0M
CashDebt
Return on Capital
0/100
-36.3%

Below 8%, may not cover cost of capital

Customize WeightsPremiumUpgrade

Baird Medical Investment Holdings (BDMD) quality: score, margins and returns

Baird Medical Investment Holdings (BDMD) scores 8/100 on Intrinsiqq's quality score (a lower-quality business), a weighted blend of 6 metrics each scored 0 to 100, on -113.3% operating margins and -36.3% ROIC. Every metric is computed from company filings; this is analysis, not investment advice.

Frequently asked

Is Baird Medical Investment Holdings (BDMD) a high-quality business?+

Baird Medical Investment Holdings scores 8 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which rates it a lower-quality business on these measures. Recent figures include a -113.3% operating margin and a -36.3% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Baird Medical Investment Holdings's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from BDMD's company filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Baird Medical Investment Holdings scores well and where it falls behind.

What is Baird Medical Investment Holdings's return on invested capital (ROIC)?+

Baird Medical Investment Holdings earns about -36.3% on its invested capital, which is weak. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to BDMD's margins and growth on this scorecard to judge durability.

How profitable is Baird Medical Investment Holdings?+

Baird Medical Investment Holdings runs an operating margin of about -113.3% and a net margin of about -122.2%. Revenue has grown at roughly -5.0% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from company filings, not investment advice.

How the market compares: US profitability statistics

Peers

Medical Devices · Pick stocks to compare with BDMD

CompareIntrinsic value
ALKLH.XPARKlea Holding Inc.
€0.16-4.48%80
ONCIN.XOSLOncoinvent ASA
kr 72.20+7.12%50
ALMDT.XPARMedian Technologies S.A.
€4.00-5.78%15
NYXHNyxoah SA
$0.81-6.29%40
NICA.XSTONanologica AB
€0.00-17.86%30
ALGEN.XPARGenoway S.A.
€1.91-2.05%22
AINO.XSTOAino Health AB
€0.01+2000.00%23
CASIFCasi Pharmaceuticals Inc
$0.10+0.10%8

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing BDMD

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.